Skip to main content

Peer Review reports

From: A pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizers

Original Submission
26 Feb 2015 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
10 Jan 2016 Editorially accepted
8 Feb 2016 Article published 10.1186/s12885-016-2062-2

You can find further information about peer review here.

Back to article page